- ￥3700
- GeneTex
- 美国
- GTX01478-11
- 2025年07月13日
- FACS
- Mouse
- Mouse
企业认证
相关产品推荐更多 >
![HLA-E antibody [MEM-E/07] (Biotin)](https://img1.dxycdn.com/2022/0328/587/8714772777985500453-14.jpg!wh200)
![Nogo Receptor antibody [6H43]](https://img1.dxycdn.com/2022/0328/800/7912476601089400453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG2a
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE. Protect from light.
- 克隆性：
Monoclonal
- 标记物：
PerCP-Cy5.5
- 适应物种：
Mouse
- 保质期：
12 months from the shipping date of the product.
- 目录编号：
GTX01478-11
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
FACS
- 浓度：
0.2 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
NK1.1
- 抗体英文名：
NK1.1 antibody [PK136] (PerCP-Cy5.5)
- 抗体名：
NK1.1 抗体 [PK136] (PerCP-Cy5.5)
- 规格：
100 μg
FACS analysis of mouse C57Bl/6 splenocytes using GTX01478-11 NK1.1 antibody [PK136] (PerCP-Cy5.5).
Right panel : co-stained with NK1.1 antibody [PK136] (PerCP-Cy5.5) and Mouse CD3e antibody (FITC)
Left panel : co-stained with isotype control and Mouse CD3e antibody (FITC)
antibody amount : 0.25 μg (5 μl)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PMID: 30041669, 2018
PMID: 11604477, 2001
PMID: 15814704, 2005
PMID: 18198346, 2008
PMID: 20733035, 2010
PMID: 21930769, 2011
PMID: 21228231, 2011
PMID: 22491248, 2012
PMID: 30572778, 2019
Fusion Proteins with Improved PK
Small recombinant antibody formats are rapidly cleared from circulation. The coupling of these molecules to human serum albumin (HSA) is an efficient strategy to prolong their in vivo half-life. Two methods are described in this chapter
Engineering of the Fc Region for Improved PK (FcRn Interaction)
high contrast images shortly after application of the radiolabeled antibody tracer or more efficient therapy with fewer administrations. This protocol describes the steps required for producing antibodies, antibody fragments or antibody Fc fusion
PEGylation of Antibody Fragments to Improve Pharmacodynamics and Pharmacokinetics
Covalent attachment of polyethylene glycol (PEG) with therapeutic proteins (PEGylation) e.g., antibodies, antibody fragments, and enzymes, has been emerged as an effective strategy to enhance the pharmacodynamics and pharmacological
技术资料暂无技术资料 索取技术资料
